Deanna L. Kirkpatrick

Davis Polk advised the underwriters on the SEC-registered initial public offering by Progyny, Inc. of 11,500,000 common shares, consisting of 6,700,000 shares sold by Progyny and 4,800,000…

Davis Polk advised the underwriters in connection with an initial public offering of 8,047,227 American Depositary Shares of Innate Pharma S.A. and a concurrent private placement of 4,452…

Davis Polk advised the underwriters in connection with the $150 million initial public offering of 10,000,000 American Depositary Shares of BioNTech SE. In addition, the underwriters have…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.15 billion aggregate principal amount of its 1.900% senior notes due 2022 and (ii) $350 million…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 2.000% bonds due October 2, 2029 issued by the Province of Ontario. The…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303,030 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 1.750% bonds due 2024, issued by the Province of British Columbia. The…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $1.25 billion aggregate principal amount of its floating-rate senior notes due 2021, under its medium-term…

Davis Polk advised Silver Spike Acquisition Corp. on its $250 million initial public offering of 25,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A…

Davis Polk advised the underwriters in connection with the offering of C$500 million aggregate principal amount of 1.650% Canadian dollar bonds due 2024 issued by Export Development Canada…